Sebastian Regnery1, Tanja Platt2. 1. Abteilung für RadioOnkologie und Strahlentherapie, Universitätsklinikum Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Deutschland. sebastian.regnery@med.uni-heidelberg.de. 2. Medizinische Physik in der Radiologie, Deutsches Krebsforschungszentrum (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland. t.platt@dkfz-heidelberg.de.
Abstract
BACKGROUND: X‑nuclei magnetic resonance imaging (MRI) yields a broad spectrum of metabolic and functional imaging techniques with increasing clinical feasibility. OBJECTIVE: Current X‑nuclei techniques in (neuro)oncology with emphasis on potential clinical applications of sodium and oxygen MRI are described and discussed. MATERIALS AND METHODS: Review with discussion of state-of-the-art literature on X‑nuclei imaging. RESULTS: X‑nuclei MRI employs NMR-sensitive nonproton nuclei to enable both anatomical visualization as well as noninvasive imaging and quantification of physiological processes in the human body. At the moment, sodium MRI represents the most common application of X‑nuclei MRI because of its comparatively high NMR signal. Moreover, its sensitivity to pathological cellular proliferation renders sodium MRI a good candidate for oncological imaging, yielding additional biochemical information to proton MRI. Oxygen MRI is currently primarily investigational, requiring high technical efforts and costs. However, preliminary results show a huge potential of this technique for metabolic characterization of tumors. CONCLUSIONS: X‑nuclei MRI is a rapidly evolving field in metabolic and functional imaging. In coming years, sodium MRI is expected to be increasingly used as an additional clinical tool in oncology to enhance diagnostic accuracy.
BACKGROUND: X‑nuclei magnetic resonance imaging (MRI) yields a broad spectrum of metabolic and functional imaging techniques with increasing clinical feasibility. OBJECTIVE: Current X‑nuclei techniques in (neuro)oncology with emphasis on potential clinical applications of sodium and oxygen MRI are described and discussed. MATERIALS AND METHODS: Review with discussion of state-of-the-art literature on X‑nuclei imaging. RESULTS: X‑nuclei MRI employs NMR-sensitive nonproton nuclei to enable both anatomical visualization as well as noninvasive imaging and quantification of physiological processes in the human body. At the moment, sodium MRI represents the most common application of X‑nuclei MRI because of its comparatively high NMR signal. Moreover, its sensitivity to pathological cellular proliferation renders sodium MRI a good candidate for oncological imaging, yielding additional biochemical information to proton MRI. Oxygen MRI is currently primarily investigational, requiring high technical efforts and costs. However, preliminary results show a huge potential of this technique for metabolic characterization of tumors. CONCLUSIONS: X‑nuclei MRI is a rapidly evolving field in metabolic and functional imaging. In coming years, sodium MRI is expected to be increasingly used as an additional clinical tool in oncology to enhance diagnostic accuracy.
Entities:
Keywords:
Diagnostic imaging; Glioma; Nuclear magnetic resonance; Oxygen consumption; Sodium
Authors: Sebastian C Niesporek; Stefan H Hoffmann; Moritz C Berger; Nadia Benkhedah; Aaron Kujawa; Peter Bachert; Armin M Nagel Journal: Neuroimage Date: 2015-03-20 Impact factor: 6.556
Authors: G Shajan; Christian Mirkes; Kai Buckenmaier; Jens Hoffmann; Rolf Pohmann; Klaus Scheffler Journal: Magn Reson Med Date: 2015-03-11 Impact factor: 4.668
Authors: Mark E Ladd; Peter Bachert; Martin Meyerspeer; Ewald Moser; Armin M Nagel; David G Norris; Sebastian Schmitter; Oliver Speck; Sina Straub; Moritz Zaiss Journal: Prog Nucl Magn Reson Spectrosc Date: 2018-06-08 Impact factor: 9.795
Authors: Ronald Ouwerkerk; Karen B Bleich; Joseph S Gillen; Martin G Pomper; Paul A Bottomley Journal: Radiology Date: 2003-03-27 Impact factor: 11.105
Authors: Keith R Thulborn; Aiming Lu; Ian C Atkinson; Mohan Pauliah; Kathryn Beal; Timothy A Chan; Antonio Omuro; Josh Yamada; Michelle S Bradbury Journal: Clin Cancer Res Date: 2018-11-28 Impact factor: 12.531
Authors: Daniel Paech; Sebastian Regnery; Tanja Platt; Nicolas G R Behl; Nina Weckesser; Paul Windisch; Katerina Deike-Hofmann; Wolfgang Wick; Martin Bendszus; Stefan Rieken; Laila König; Mark E Ladd; Heinz-Peter Schlemmer; Jürgen Debus; Sebastian Adeberg Journal: Front Neurosci Date: 2021-12-01 Impact factor: 4.677